01:31 , Jun 3, 2008 |  BC Extra  |  Financial News

Inimex raises $22 million

Inimex (Vancouver, B.C.) raised $22 million in a series B round led by new investor Morningside Venture Investments. Roche Venture Fund; Astellas Venture Management; and Advantage Life Science Fund II, also new investors, joined existing...
07:00 , Oct 8, 2007 |  BC Week In Review  |  Company News

Gemin X Biotechnologies Inc. board of directors update

Gemin X Biotechnologies Inc. , Montreal, Quebec   Business: Cancer   Appointed: Eric Roberts, managing director of Caxton Advantage Life Science Fund L.P.  ...